Connor Clark & Lunn Investment Management LTD Holding in Cae (CAE) Upped as Market Valuation Rose; Shaker Investments Holding in Abiomed (ABMD) Upped by $688,800 as Valuation Rose

January 18, 2018 - By Darrin Black

Connor Clark & Lunn Investment Management Ltd increased its stake in Cae Inc. (CAE) by 12.4% based on its latest 2017Q3 regulatory filing with the SEC. Connor Clark & Lunn Investment Management Ltd bought 956,184 shares as the company’s stock rose 0.90% with the market. The institutional investor held 8.67M shares of the industrial machinery and components company at the end of 2017Q3, valued at $151.34 million, up from 7.71 million at the end of the previous reported quarter. Connor Clark & Lunn Investment Management Ltd who had been investing in Cae Inc. for a number of months, seems to be bullish on the $4.90B market cap company. The stock decreased 0.54% or $0.1 during the last trading session, reaching $18.55. About 45,672 shares traded. CAE Inc. (NYSE:CAE) has risen 26.75% since January 18, 2017 and is uptrending. It has outperformed by 10.05% the S&P500.

Shaker Investments Llc increased its stake in Abiomed Inc (ABMD) by 23.44% based on its latest 2017Q3 regulatory filing with the SEC. Shaker Investments Llc bought 4,100 shares as the company’s stock rose 15.32% with the market. The institutional investor held 21,595 shares of the health care company at the end of 2017Q3, valued at $3.64 million, up from 17,495 at the end of the previous reported quarter. Shaker Investments Llc who had been investing in Abiomed Inc for a number of months, seems to be bullish on the $9.96 billion market cap company. The stock increased 0.50% or $1.11 during the last trading session, reaching $225.24. About 69,162 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 40.97% since January 18, 2017 and is uptrending. It has outperformed by 24.27% the S&P500.

Connor Clark & Lunn Investment Management Ltd, which manages about $26.75 billion and $16.66 billion US Long portfolio, decreased its stake in Lyondellbasell Indu (NYSE:LYB) by 92,625 shares to 98,650 shares, valued at $9.77 million in 2017Q3, according to the filing. It also reduced its holding in Manulife Financial Corp. (NYSE:MFC) by 1.54M shares in the quarter, leaving it with 17.04 million shares, and cut its stake in Celestica Inc. (NYSE:CLS).

Investors sentiment increased to 1.29 in Q3 2017. Its up 0.14, from 1.15 in 2017Q2. It improved, as 9 investors sold CAE shares while 47 reduced holdings. 20 funds opened positions while 52 raised stakes. 132.48 million shares or 2.20% less from 135.47 million shares in 2017Q2 were reported. Us Retail Bank De reported 12,164 shares. Uss Inv Management Ltd invested 0.37% of its portfolio in CAE Inc. (NYSE:CAE). Quantbot Technology Ltd Partnership has 1,066 shares for 0% of their portfolio. Hsbc Public Lc reported 139,986 shares. Ontario Teachers Pension Plan Board accumulated 316,496 shares. Lombard Odier Asset (Switzerland) owns 27,447 shares or 0.06% of their US portfolio. Bancorporation Of America Corporation De stated it has 0% in CAE Inc. (NYSE:CAE). Account Mngmt Ltd Co stated it has 3.21% in CAE Inc. (NYSE:CAE). Magnetar Finance Ltd Limited Liability Company stated it has 0.01% in CAE Inc. (NYSE:CAE). Glenmede Trust Na invested in 0% or 1,242 shares. Bnp Paribas Asset Management Hldgs Sa has 1.01 million shares. Amp Cap Invsts has 0.02% invested in CAE Inc. (NYSE:CAE). Arrowstreet Cap Limited Partnership owns 749,671 shares. 418,744 were accumulated by Agf Invests Inc. Td Asset Mngmt Inc holds 0.18% or 6.73 million shares.

Among 9 analysts covering CAE Inc. (NYSE:CAE), 5 have Buy rating, 1 Sell and 3 Hold. Therefore 56% are positive. CAE Inc. had 16 analyst reports since August 13, 2015 according to SRatingsIntel. The firm has “Market Perform” rating given on Friday, May 20 by BMO Capital Markets. On Friday, November 11 the stock rating was downgraded by IBC to “Sector Perform”. Zacks downgraded the shares of CAE in report on Wednesday, August 26 to “Hold” rating. As per Friday, May 6, the company rating was upgraded by National Bank Canada. The stock has “Outperform” rating by Macquarie Research on Friday, May 27. The rating was upgraded by Desjardins Securities on Thursday, August 13 to “Buy”. As per Tuesday, September 22, the company rating was downgraded by Zacks. The firm has “Outperform” rating given on Friday, February 12 by BMO Capital Markets. RBC Capital Markets downgraded CAE Inc. (NYSE:CAE) rating on Friday, November 11. RBC Capital Markets has “Sector Perform” rating and $20 target. The rating was downgraded by TD Securities to “Hold” on Thursday, June 1.

Among 12 analysts covering Abiomed (NASDAQ:ABMD), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. Abiomed had 26 analyst reports since August 4, 2015 according to SRatingsIntel. As per Tuesday, August 9, the company rating was maintained by Jefferies. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Thursday, June 8 by William Blair. The company was maintained on Wednesday, August 5 by Piper Jaffray. Piper Jaffray maintained it with “Buy” rating and $220.0 target in Thursday, January 4 report. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Thursday, September 21 by Jefferies. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Jefferies on Thursday, November 2. The firm has “Buy” rating given on Friday, September 29 by SunTrust. The firm earned “Market Perform” rating on Wednesday, August 5 by Northland Capital. The rating was maintained by Jefferies on Thursday, December 21 with “Buy”. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Outperform” rating given on Wednesday, May 4 by Leerink Swann.

Investors sentiment decreased to 1.3 in 2017 Q3. Its down 0.13, from 1.43 in 2017Q2. It fall, as 27 investors sold ABMD shares while 89 reduced holdings. 55 funds opened positions while 96 raised stakes. 38.51 million shares or 1.21% less from 38.99 million shares in 2017Q2 were reported. Commonwealth Of Pennsylvania Pub School Empls Retrmt Sys has invested 0.02% in ABIOMED, Inc. (NASDAQ:ABMD). Dorsey And Whitney Trust Communications Lc accumulated 0.04% or 1,276 shares. Sei Invests holds 0.09% or 150,284 shares. Great West Life Assurance Can accumulated 0.01% or 30,836 shares. Alyeska Inv Group Lp holds 0.16% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 120,147 shares. Swiss Bank & Trust reported 69,600 shares. Hamilton Lane Advsr Limited Liability accumulated 15,414 shares or 1.78% of the stock. Moreover, Ubs Asset Mngmt Americas has 0.02% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 106,016 shares. Sg Americas Llc accumulated 4,302 shares or 0.01% of the stock. Sectoral Asset reported 2.79% stake. 51,729 are held by Perceptive Advsr Limited Liability Company. Citigroup Incorporated holds 0% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 1,343 shares. Aqr Cap Mgmt Lc holds 0.01% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 51,131 shares. Louisiana State Employees Retirement has invested 0.09% in ABIOMED, Inc. (NASDAQ:ABMD). Advisory Svcs Network Ltd reported 540 shares stake.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com